CARL K GJERTSON
Allopathic & Osteopathic Physicians|Urology FARMINGTON, CT NPI 1063472017
Browse related groups: Allopathic & Osteopathic Physicians|Urology CT Genmab U.S., Inc. All categories
General Payments — all program years on this page
$880.59
- Category: General Payments
- Program years: PY2018–2024
- Record count: 39
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $139.63 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $139.63 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Genmab U.S., Inc. | $38.89 | 2 |
| Tempus AI, Inc | $19.62 | 1 |
| EISAI INC. | $17.50 | 1 |
| SOBI, INC | $17.24 | 1 |
| TerSera Therapeutics LLC | $15.75 | 1 |
| Janssen Biotech, Inc. | $15.69 | 1 |
| Astellas Pharma US Inc | $14.94 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078374929 | Janssen Biotech, Inc. | $15.69 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1110735417 | Eisai Inc. | $17.50 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1126825115 | Genmab U.S., Inc. | $18.76 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1126825117 | Genmab U.S., Inc. | $20.13 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139409655 | Astellas Pharma US Inc | $14.94 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141412504 | SOBI, INC | $17.24 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144713377 | TerSera Therapeutics LLC | $15.75 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150165190 | Tempus AI, Inc | $19.62 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.